Senior Compliance Leader - ISO & Quality Excellence

Autolomous; Greater London; Hybrid; GBP 60,000 - 80,000; Full time

Benefits offered by this job

Full immersion in a fast-moving startup

Development opportunities

Market competitive salaries and pay reviews

Top-of-the-range home office equipment

Salary Sacrifice Pension plan

Job summary

Autolomous is seeking a Senior Compliance Manager in London to ensure compliance and quality standards. This pivotal role involves leading ISO certifications and embedding a culture of quality across departments. Your proactive approach will drive key performance indicators while overseeing compliance frameworks essential for our evolution.

The ideal candidate will have extensive experience in auditing and ISO standards maintenance, focusing on growth and oversight in the advanced therapies sector.

Qualifications

• Concrete experience with both internal and external auditing.
• Experience maintaining ISO standards 9001, 27001, 13485, and 14001.
• Strong time-management capabilities and keen attention to detail.

Responsibilities

• Support and lead IMS audit life cycle aspects.
• Produce and present IMS status reports to management.
• Document corrective actions and track remediation progress.
• Train staff to report non-conformances.
• Perform investigations on non-conformance reports.

Skills

Internal and external auditing experience

ISO 9001, ISO 27001, ISO 13485, ISO 14001 standards maintenance

Organizational skills

Time-management capabilities

Creative problem solving

Job description

Autolomous is seeking a Senior Compliance Manager in London to ensure compliance and quality standards. This pivotal role involves leading ISO certifications and embedding a culture of quality across departments. Your proactive approach will drive key performance indicators while overseeing compliance frameworks essential for our evolution.

The ideal candidate will have extensive experience in auditing and ISO standards maintenance, focusing on growth and oversight in the advanced therapies sector.